The stories started appearing everywhere: women who had struggled with infertility for years suddenly getting pregnant after starting GLP-1 medications. Women who thought they couldn't conceive. Women whose birth control "failed." The term "Ozempic babies" caught fire on social media.
Is this real? What's actually happening? And what should you know if you're taking GLP-1 medications and pregnancy is—or isn't—in your plans?
Let's separate the science from the hype.
The Phenomenon Is Real (But Context Matters)
First, the important clarification: there are no large clinical trials specifically studying GLP-1 medications and fertility. The "Ozempic babies" phenomenon is largely documented through anecdotes, case reports, and mechanistic reasoning. That doesn't mean it's not real—it means we're working with incomplete data.
What we do know:
- Many women report unexpected pregnancies after starting GLP-1 medications
- Women with PCOS (a leading cause of infertility) show improved hormonal profiles on GLP-1s
- Weight loss itself restores fertility in many cases
- There may be drug interactions with some birth control methods
The pregnancies are likely happening through multiple mechanisms, not a single cause.
Mechanism #1: Weight Loss Restores Ovulation
This is probably the biggest factor. Obesity disrupts the hormonal signaling required for regular ovulation. Excess fat tissue:
- Produces extra estrogen (fat cells convert androgens to estrogen)
- Increases insulin resistance, which raises testosterone
- Disrupts the hypothalamic-pituitary-ovarian axis
- Creates chronic low-grade inflammation affecting reproductive function
The result: irregular or absent periods, inconsistent ovulation, and reduced fertility. Studies show that 5-10% weight loss can restore ovulation in many women with obesity-related infertility. GLP-1 medications produce 15-20% weight loss—more than enough to tip the balance.
The Numbers on Weight Loss and Fertility
Research shows:
- 5-10% weight loss restores menstrual regularity in ~50% of women with obesity-related anovulation
- Each 1 kg/m² decrease in BMI increases the odds of spontaneous ovulation by ~6%
- Women who lost >5% body weight before fertility treatment had significantly higher pregnancy rates
For women who hadn't been ovulating—or had been ovulating irregularly—losing significant weight on GLP-1 medications can suddenly make pregnancy possible when it wasn't before.
Mechanism #2: Improved Insulin Sensitivity
GLP-1 medications improve insulin sensitivity independent of weight loss. This matters enormously for fertility because:
Insulin resistance → High insulin → High androgens → Disrupted ovulation
When insulin sensitivity improves:
- The ovaries receive less "signal" to produce testosterone
- Sex hormone-binding globulin (SHBG) increases, reducing free androgens
- The hormonal environment becomes more favorable for follicle development
- Ovulation becomes more regular
This mechanism is particularly relevant for women with PCOS, where insulin resistance is often a core driver of infertility.
Mechanism #3: PCOS-Specific Improvements
Polycystic ovary syndrome (PCOS) affects 8-13% of women of reproductive age and is one of the leading causes of infertility. GLP-1 medications appear remarkably effective for PCOS:
Meta-analysis of clinical trials found GLP-1 agonists in PCOS patients reduced waist circumference by 5.16 cm and BMI by 2.42 kg/m², with substantial testosterone reduction. Many women reported menstrual cycle normalization.
For women with PCOS who had irregular or absent periods, GLP-1 treatment can restore regular cycles—and with regular cycles comes regular ovulation and sudden fertility.
The surprise factor: Many women with PCOS have been told they'll struggle to conceive. They may have stopped using birth control or become less vigilant because they didn't think pregnancy was possible. Then GLP-1 treatment normalizes their hormones, and pregnancy happens unexpectedly.
Mechanism #4: Birth Control Interactions
This one is more complex and depends on which GLP-1 medication you're taking.
Tirzepatide and Oral Contraceptives
Tirzepatide (Mounjaro/Zepbound) has documented interactions with oral contraceptives. The mechanism: GLP-1 medications slow gastric emptying, which can affect how quickly oral medications are absorbed.
Studies show tirzepatide reduces oral contraceptive exposure by approximately 20%. While this doesn't necessarily mean the pill won't work, it reduces the safety margin.
Manufacturer recommendation for tirzepatide:
- Use backup contraception for 4 weeks after initiating tirzepatide
- Use backup contraception for 4 weeks after each dose increase
- Consider switching to non-oral contraception (IUD, implant, injection)
Semaglutide and Oral Contraceptives
The picture is different for semaglutide. A pharmacokinetic study specifically examined whether weekly semaglutide affects oral contraceptive bioavailability. The finding: no clinically significant reduction in ethinylestradiol or levonorgestrel levels.
This suggests semaglutide doesn't have the same interaction concern as tirzepatide. However, the study was small, and the FDA has not definitively ruled out any interaction. Most providers still recommend caution.
| GLP-1 Medication | Birth Control Interaction | Recommendation |
|---|---|---|
| Tirzepatide | ~20% reduction in oral contraceptive exposure | Backup method for 4 weeks after start/dose changes; consider non-oral options |
| Semaglutide (weekly) | No significant effect in PK study | Standard precautions; consider backup if concerned |
| Liraglutide (daily) | Possible minor effect (shorter-acting) | Standard precautions |
| Oral semaglutide | Potential interaction (oral form) | More caution warranted; consider backup |
The safest options for contraception while on GLP-1 medications—if you definitely don't want pregnancy—are non-oral methods: IUDs, implants, injections, or barrier methods.
If You Want to Get Pregnant
For women who want to conceive, the fertility-enhancing effects of GLP-1 medications might seem like good news. But there's a critical complication: GLP-1 medications are not recommended during pregnancy.
Why You Should Stop Before Trying
Animal studies with semaglutide and tirzepatide showed embryofetal mortality and structural abnormalities at clinically relevant exposures. While human data is limited, the FDA categorizes these medications as contraindicated in pregnancy.
One BMJ study examining first-trimester exposure found it was NOT associated with increased major birth defects—which is reassuring if accidental exposure occurs—but this doesn't mean the medications are safe to use intentionally during pregnancy.
Recommended Washout Periods Before Planned Pregnancy
The Fertility-Boosting Strategy
Some fertility specialists are using GLP-1 medications strategically:
- Use GLP-1 medication to achieve significant weight loss (3-6+ months)
- Restore hormonal balance and regular ovulation
- Stop medication for required washout period
- Attempt conception with improved fertility profile
The hope is that the metabolic improvements persist long enough after stopping to allow conception. This is a reasonable approach, though it requires careful timing and provider guidance.
Important consideration: If you've had longstanding infertility, work with both your weight management provider and a reproductive endocrinologist to coordinate care. The transition off GLP-1 medications should be planned carefully.
If You Definitely Don't Want to Get Pregnant
The takeaway here is straightforward: don't assume you can't get pregnant just because you haven't been able to before, especially if you have PCOS or obesity-related fertility issues.
Contraception Recommendations on GLP-1s
Most reliable options:
- IUD (hormonal or copper): Not affected by GLP-1 medications or GI changes
- Implant (Nexplanon): Not affected; highly effective
- Injection (Depo-Provera): Not affected by oral absorption issues
Requires extra caution:
- Oral contraceptives: Especially with tirzepatide; use backup method during initiation and dose changes
- Oral progestin-only pills: Similar concerns about absorption
- Vaginal ring: Should be unaffected (not oral), but limited data
Always effective (user-dependent):
- Condoms: No medication interaction; requires consistent use
- Diaphragm/cervical cap: No interaction; requires proper use
What If You Get Pregnant While on GLP-1s?
If you discover you're pregnant while taking a GLP-1 medication, don't panic—but do act quickly:
- Stop the medication immediately. Contact your prescriber right away.
- Contact your OB-GYN or midwife. Early prenatal care is important.
- Know that accidental exposure isn't necessarily harmful. The BMJ study found no increased birth defect risk with first-trimester exposure. Many healthy pregnancies have occurred after GLP-1 exposure.
- Get appropriate monitoring. Your provider may recommend additional ultrasounds or testing.
The key is that continuing the medication during pregnancy is not recommended, but brief exposure before you knew you were pregnant is not a reason for alarm or automatic termination.
GLP-1 and Male Fertility
The "Ozempic babies" conversation focuses on women, but what about men? GLP-1 medications may actually improve male fertility through several mechanisms:
Testosterone Improvements in Men
An 18-month retrospective study of 110 males on semaglutide found:
- Average testosterone increase from 320 ng/dL to 368 ng/dL (+48 ng/dL)
- Men with healthy testosterone (>300 ng/dL) increased from ~50% to 77%
- Improvements comparable to testosterone replacement therapy in some cases
Critically, unlike testosterone replacement therapy (TRT), GLP-1 medications don't suppress sperm production. A comparison study found semaglutide increased testosterone comparably to TRT while maintaining sperm quality—TRT reduced sperm concentration by 60.6%.
For men with obesity-related hypogonadism (low testosterone) who want to preserve fertility, GLP-1 medications may be preferable to TRT.
Breastfeeding Considerations
What about after pregnancy? Can you take GLP-1 medications while breastfeeding?
The data is limited but becoming clearer:
- Preliminary 2025 data (5 women) showed tirzepatide was barely detectable in breastmilk—below the limit of detection of 0.7 mcg/L
- NIH LactMed states that if a mother requires tirzepatide, "it is not a reason to discontinue breastfeeding"
- The large molecular size of these peptides makes significant transfer into breastmilk unlikely
However:
- Oral semaglutide is NOT recommended during breastfeeding due to the absorption enhancer (SNAC/salcaprozate sodium)
- Long-term infant exposure data doesn't exist
- Most providers recommend caution and shared decision-making
If postpartum weight management is a priority and you're breastfeeding, discuss the risks and benefits with your provider. For many women, waiting until weaning may be the most conservative choice, but it's not the only reasonable option.
The Psychological Dimension
Beyond the biology, there's an important psychological aspect to "Ozempic babies."
Many women who struggle with weight have complicated relationships with their bodies. Being told you're "too heavy" to get pregnant adds another layer of pain. Then years of trying, failing, and possibly giving up on the dream of biological children.
When GLP-1 medications suddenly make pregnancy possible, the emotions are complex:
- Joy at the pregnancy itself
- Grief for years lost to infertility
- Anger that weight loss was presented as the "solution" they needed
- Guilt if they feel they should have lost weight earlier
- Fear about what to do now that pregnancy happened unexpectedly
If you're processing an unexpected pregnancy—wanted or not—give yourself grace. The emotions are valid. Seeking support from a therapist who understands both fertility struggles and weight management can help.
Key Takeaways
The Bottom Line on GLP-1s and Fertility
- GLP-1 medications can restore fertility in women with obesity-related infertility, especially PCOS
- Multiple mechanisms: weight loss, improved insulin sensitivity, hormonal normalization, and possibly birth control interactions
- If you don't want pregnancy: Use reliable contraception (preferably non-oral); don't assume infertility will protect you
- If you want pregnancy: Stop medication 2 months before trying; work with providers to time the transition
- If pregnancy happens unexpectedly: Stop medication, seek prenatal care, don't panic—accidental exposure data is reassuring
- Tirzepatide has documented birth control interactions; semaglutide appears to have less effect, but caution is still warranted
The "Ozempic babies" phenomenon is real, rooted in legitimate biological mechanisms, and something every woman of reproductive age should understand before starting GLP-1 treatment. Whether pregnancy is your goal or something to prevent, knowing how these medications affect fertility helps you make informed decisions.
Questions About GLP-1 and Fertility?
Find providers who can discuss family planning alongside weight management.
Compare Providers